Trial Profile
Efficacy and Safety Study of the Ivabradine Hydrochloride Tablets versus Atenolol Tablets in Patients With Chronic Stable Angina Pectoris.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Atenolol
- Indications Angina pectoris
- Focus Therapeutic Use
- 22 Apr 2014 Primary endpoint 'Exercise-time' has been met.
- 22 Apr 2014 Results published in the Pharmacoepidemiology and Drug Safety.
- 13 Jun 2013 New trial record